Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
102 participants
OBSERVATIONAL
2014-12-31
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Tube Feeding Tolerance in Adults With Intolerance After Switch to a Peptide-Based Formula
NCT03048409
Feeding Trial in Pediatric Patients
NCT01469117
Enteral Formula Tolerance in Pediatric Patients
NCT02779335
Nutritional Tolerance and Safety of a Tube Feeding Formula in Children
NCT05838495
Acceptability and Tolerance Study of a Low Calorie Peptide Based Paediatric Tube Feed Formula.
NCT03718208
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
enterally fed adults
adult subjects with established enteral access receiving standard tube feeding formula
enteral formula
standard tube feeding formulas
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
enteral formula
standard tube feeding formulas
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently tolerating enteral feeding
* Has enteral access
* Requires enteral tube feeding to provide 90% or more of their nutritional needs (without the use of modular(s)) for at least 21 days
* Having obtained his/her and/or his/her legal representative's informed consent.
Exclusion Criteria
* Lack of enteral access
* Any condition that would contraindicate use of the study product (i.e. need for severe fluid restriction, cow's milk protein allergy, other)
* Currently participating in another conflicting clinical study that would interfere with anticipated endpoints
* Judged to be at risk for poor compliance to the study protocol.
* Lack of informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arkansas
Little Rock, Arkansas, United States
Vanderbilt University
Nashville, Tennessee, United States
Bruyere Research Institute
Ottawa, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14.01.US.HCN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.